Top Stories

A McDonald's employee in Kansas has been fired and is facing criminal charges after the worker put mustard in an official's beverage. Two officers with the Topeka Police Department said that on Friday, they bought a Dr. Pepper at a McDonald's drive-thru...


European Central Bank President Mario Draghi asserted that the option of scaling back bond purchases gradually to zero, or 'tapering', was not discussed by policymakers on Thursday, but said the bank was ready to extend and boost stimulus when needed. Earlier...


Fast food executive Andrew Puzder is expected to be announced as President-elect Donald Trump's nominee for Labor Secretary, according to numerous media reports. Puzder currently serves as Chief Executive Officer of CKE Restaurants, Inc., the parent...


Stocks continue to turn in a relatively lackluster performance in mid-day trading on Thursday as traders digest the European Central Bank's highly anticipated monetary policy announcement. The major averages still managed to reach new record intraday...


Victoria Secret model Irina Shayk and actor Bradley Cooper are expecting their first child together, according to multiple sources. According to one insider, the pregnant star is in her second trimester and is "so excited" about becoming a mother...

FeatureCapitol-120116.jpg A bill extending existing U.S. sanctions on Iran for ten years was unanimously approved by the Senate on Thursday and is now headed to President Barack Obama's desk. The Senate voted 99 to zero in favor of the Iran Sanctions Extension Act.
Wallstreet-013013_01Dec16.jpg With traders digesting OPEC's decision to curtail oil output as well as the latest batch of U.S. economic data, stocks turned in a mixed performance on Thursday. While the Dow reached a new record closing high, the tech-heavy Nasdaq showed a notable decline.
Asian-Markets2_01Dec16.jpg Asian stock markets are mostly lower on Friday following the lackluster cues overnight from Wall Street and on caution ahead of the release of the closely-watched U.S. jobs data later in the day, in addition to the Italian referendum and elections in Austria this weekend.
Pharma-120216.jpg Shares of Aradigm Corp. (ARDM) plunged over 56% on Thursday after two phase III studies evaluating Pulmaquin for the chronic treatment of Non-Cystic Fibrosis Bronchiectasis patients with lung infections with Pseudomonas aeruginosa delivered a mixed bag of results.
AndyPuzder-120916.jpg Fast food executive Andrew Puzder is expected to be announced as President-elect Donald Trump's nominee for Labor Secretary, according to numerous media reports. Puzder currently serves as Chief Executive Officer of CKE Restaurants, Inc., the parent company of Carl's Jr., Hardee's, Green Burrito, and Red Burrito.
capitol-reflecting-120716.jpg Senators overwhelmingly voted in favor of a $6.3 billion medical innovation bill on Wednesday, sending the legislation to President Barack Obama's desk for his signature. The Senate voted 94 to 5 in favor of the bill known as the 21st Century Cures Act.
ECB-Draghi-120616.jpgEuropean Central Bank President Mario Draghi will likely announce an extension of asset purchases by the central bank beyond March 2017 on Thursday, hoping to spread some Christmas cheer amid the high political uncertainty, especially after the 'no' vote in the Italian referendum last weekend.
Older adults who suffer from dementia, or mild cognitive impairment, may benefit from aerobic exercise, according to a new study. The study, to be presented Wednesday at the Radiological Society of North America, included 16 people with an average age of 63, who did aerobic workouts on a treadmill, stationary bike or elliptical training. They worked out four times a week for six months.
The European markets were largely flat in early trade Thursday, ahead of today's announcement from the European Central Bank. However, they broke out higher after the central bank surprised the markets. The ECB announced that bond purchases will be extended till the end of next year, which is longer-than-expected,...
Retailer Sears Holdings Corp. reported Thursday wider net loss in its third quarter, hurt by weak revenues and comparable store sales. Edward Lampert, Chairman and Chief Executive Officer, said, "We remain fully committed to restoring profitability to our Company and are taking actions such as reducing unprofitable stores, reducing space in stores we continue to operate (including throug
Talks are gaining ground that the anti-regulation mindset of president-elect Donald Trump may not spare even the FDA. The first 100 days action plan released by Trump in late October suggested that he may seek to cut the red tape at the FDA, ensuring expedited drug approval processes. More
Eli Lilly and Co. (LLY) said that the neoMONARCH study of abemaciclib, a cyclin-dependent kinase or CDK 4 and CDK 6 inhibitor, met its primary endpoint of reducing expression of Ki67, a biomarker of cell proliferation, after two weeks of treatment. Final... More
Fitbit-Pebble-120716.jpg Wearable fitness device maker Fitbit Inc. said it has acquired the assets of struggling smartwatch startup Pebble, including key personnel and intellectual property related to software and firmware development. The acquisition excludes Pebble's hardware products. Financial terms of the deal were not disclosed.
Follow RTT
Economic Calendar
12/08/16 10:30EIA Natural Gas Inventory (Cubic Feet)DEC 02 United States
12/08/16 9:0CPI (M-o-M)NOV Mexico
12/08/16 9:0CPI (Y-o-Y)NOV Mexico
12/08/16 9:0PPI (M-o-M)NOV Mexico
12/08/16 9:0PPI (Y-o-Y)NOV Mexico
12/08/16 8:30New Housing Price Index (M-o-M)OCT Canada
Complete Economic Calendar
FDA Calendar
Event DateSymbolDrug NameEvent Name
03/02/17BMYOpdivo (sBLA)FDA decision on Opdivo for patients with locally advanced unresectable or metastatic urothelial carcinoma that has progressed on or after platinum-containing therapy
02/28/17LXRXTelotristat Etiprate (NDA)FDA decision on Telotristat Etiprate for the treatment of carcinoid syndrome
02/23/17CLVSRucaparib (NDA)FDA decision on Rucaparib for the treatment of advanced mutant BRCA ovarian cancer.
02/17/17GMXAY.PK, GNMSF.OBDARZALEX in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone (sBLA)FDA decision on DARZALEX combination for relapsed multiple myeloma
02/16/17NBIXINGREZZA (NDA)FDA panel to review INGREZZA for tardive dyskinesia
Complete FDA Calendar